Humana Inc.
NYSE:HUMMedical - Healthcare Plans
+$0.70 today
- Market cap
- $46.32B
- Beta
- 0.77
- P/E (TTM)
- 38.6
- EPS (TTM)
- $9.39
- Dividend yield
- 0.98%
Volume 4.06M
Average 1.72M
HUM Operating Cash Flow
Cash generated by the company's core business operations during the period.
Humana Inc.NYSE: HUM
Operating Cash Flow · Q3 FY2026 · quarter ended Sep 2026
Operating cash flow growth accelerates
Q3 FY2026 operating cash flow of $2.16B rose 122.8% year over year, ahead of the -34.5% change in trailing-twelve-month operating cash flow. Over 3 fiscal years it compounded at -41.4% a year.
Context
- Operating cash flow amounted to 0.7% of revenue in FY2025, down 1.8 pp from a year earlier.
- Operating cash flow increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +122.8% holds above the trailing-twelve-month pace of -34.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 921M USD
- Year-over-year change
- -68.9%
- 4-year CAGR
- -20.1%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 921M | -68.9% |
| FY2024 | 2024-12-31 | 2.97B | -25.5% |
| FY2023 | 2023-12-31 | 3.98B | -13.2% |
| FY2022 | 2022-12-31 | 4.59B | +102.8% |
| FY2021 | 2021-12-31 | 2.26B | — |
Operating Cash Flow vs competitors
How HUM compares with its peers on the latest reported figures
- HUM's LTM Sep 2026 operating cash flow of $1.34B is the 7th largest of the 9 companies compared; the peer median is $8.51B.
- Its year-over-year change of -34.5% is the lowest of 9, against a peer median of +133.5%.
- Operating cash flow amounts to 0.9% of revenue for HUM, versus a peer median of 4.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $26.2B | +25.0% | -9.1% | 5.8% | |
| LTM Jun 2026 | $14.78B | +95.3% | -13.0% | 3.6% | |
| LTM Jun 2026 | $9.77B | +464.5% | -6.7% | 5.0% | |
| LTM Sep 2026 | $9.43B | +8.8% | +3.5% | 3.3% | |
| LTM Sep 2026 | $7.6B | +54.6% | -20.1% | 3.8% | |
| LTM Jun 2026 | $4.37B | +254.3% | +42.3% | 28.6% | |
| LTM Sep 2026 | $1.34B | -34.5% | -41.4% | 0.9% | |
| LTM Sep 2026 | $331M | +171.8% | — | 0.8% | |
| LTM Mar 2026 | $251.99M | +337.3% | — | 5.9% | |
| Peer median (excluding HUM) | $8.51B | +133.5% | -7.9% | 4.4% | |
Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.93B | 2.8B | 2.49B | 1.21B | 1.2B |
| Depreciation & Amortization | 713M | 845M | 917M | 968M | 824M |
| Deferred Income Tax | 15M | (100M) | (167M) | (192M) | 75M |
| Stock-Based Compensation | 180M | 216M | 175M | 207M | 241M |
| Change in Working Capital | (556M) | 534M | 81M | 154M | (1.8B) |
| Accounts Receivables | (280M) | (54M) | (337M) | (669M) | (570M) |
| Inventory | 0 | 0 | (364M) | 0 | 0 |
| Accounts Payables | 104M | 975M | 915M | 199M | (472M) |
| Other Working Capital | (380M) | (387M) | (133M) | 624M | (755M) |
| Other Non-Cash Items | (1.02B) | 290M | 486M | 615M | 375M |
| Operating Cash Flow | 2.26B | 4.59B | 3.98B | 2.97B | 921M |
| Capital Expenditures | (1.34B) | (1.14B) | (1B) | (575M) | (546M) |
| Acquisitions (Net) | (4.19B) | 2.36B | (233M) | (89M) | (81M) |
| Purchases of Investments | (7.2B) | (6.05B) | (7.55B) | (8.19B) | (6.44B) |
| Sales of Investments | 6.14B | 3.8B | 5.09B | 6.36B | 9.42B |
| Other Investing Activities | 26M | 17M | 210M | (461M) | (82M) |
| Investing Cash Flow | (6.56B) | (1.01B) | (3.49B) | (2.95B) | 2.27B |
| Debt Repayment | 3.76B | (1.39B) | 423M | 218M | 431M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (79M) | (2.1B) | (1.57B) | (817M) | (151M) |
| Dividends Paid | (354M) | (392M) | (431M) | (431M) | (430M) |
| Other Financing Activities | (310M) | 1.97B | 725M | (1.46B) | (1.07B) |
| Financing Cash Flow | 3.02B | (1.91B) | (856M) | (2.49B) | (1.22B) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (1.28B) | 1.67B | (367M) | (2.47B) | 1.98B |
| Free Cash Flow | 920M | 3.45B | 2.98B | 2.39B | 375M |
Humana Inc.
NYSE:HUM
Intrinsic Alpha fair value
Locked
Current Price
$385.71
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.